Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial

Clinical trial NCT05405868 · RECRUITING

Trial details

NCT number: NCT05405868
Sponsor: University College, London
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Glaucoma, Open-Angle

Start date: 2024-01-18
Primary completion: 2027-04-30
Enrollment: 496

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.